We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$143M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$19M
3
AGN
Allergan plc
AGN
+$15M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$13.8M
5
MUB icon
iShares National Muni Bond ETF
MUB
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DX
2126
Dynex Capital
DX
$3.22B
$131K ﹤0.01%
9,188
– –
STSA
2127
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$131K ﹤0.01%
+4,565
New +$106K
TXMD icon
2128
TherapeuticsMD
TXMD
$24.1M
$131K ﹤0.01%
2,101
+1,161
+124% +$67.6K
TRC icon
2129
Tejon Ranch
TRC
$441M
$131K ﹤0.01%
9,079
– –
HCCI
2130
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$130K ﹤0.01%
7,474
– –
LORL
2131
DELISTED
Loral Space and Communications, Inc.
LORL
$130K ﹤0.01%
6,669
– –
VPG icon
2132
Vishay Precision Group
VPG
$934M
$129K ﹤0.01%
5,267
– –
SNR
2133
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$129K ﹤0.01%
35,722
– –
PRPL icon
2134
Purple Innovation
PRPL
$28.4M
$129K ﹤0.01%
+287
New +$90.5K
SLCA
2135
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$129K ﹤0.01%
+35,770
New +$90.3K
MOD icon
2136
Modine Manufacturing
MOD
$10.6B
$128K ﹤0.01%
23,187
– –
MGTX icon
2137
MeiraGTx Holdings
MGTX
$1.2B
$128K ﹤0.01%
10,217
+3,689
+57% +$51.4K
ASIX icon
2138
AdvanSix
ASIX
$427M
$128K ﹤0.01%
10,869
– –
ANIP icon
2139
ANI Pharmaceuticals
ANIP
$1.73B
$128K ﹤0.01%
3,945
– –
UBX
2140
DELISTED
Unity Biotechnology
UBX
$127K ﹤0.01%
+1,468
New +$109K
EQBK icon
2141
Equity Bancshares
EQBK
$1.06B
$127K ﹤0.01%
7,293
– –
ACBI
2142
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$127K ﹤0.01%
10,440
– –
BNFT
2143
DELISTED
Benefitfocus, Inc.
BNFT
$127K ﹤0.01%
11,793
– –
MCS icon
2144
Marcus Corp
MCS
$914M
$127K ﹤0.01%
9,550
– –
AVXL icon
2145
Anavex Life Sciences
AVXL
$316M
$127K ﹤0.01%
+25,756
New +$97.3K
TCRR
2146
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$126K ﹤0.01%
+8,211
New +$94.7K
KRMD icon
2147
KORU Medical Systems
KRMD
$152M
$126K ﹤0.01%
+13,993
New +$141K
SXC icon
2148
SunCoke Energy
SXC
$801M
$125K ﹤0.01%
42,209
– –
PACK icon
2149
Ranpak Holdings
PACK
$464M
$124K ﹤0.01%
+16,724
New +$123K
CYH icon
2150
Community Health Systems
CYH
$410M
$124K ﹤0.01%
41,228
– –
84 85
86
87 88

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.